RedHill Financial Statements From 2010 to 2024
RedHill Biopharma financial statements provide useful quarterly and yearly information to potential RedHill Biopharma investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on RedHill Biopharma financial statements helps investors assess RedHill Biopharma's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting RedHill Biopharma's valuation are summarized below:RedHill Biopharma does not presently have any trending fundamental ratios for analysis.
This module can also supplement various RedHill Biopharma Technical models . Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Check RedHill Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RedHill main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . RedHill financial statements analysis is a perfect complement when working with RedHill Biopharma Valuation or Volatility modules.
RedHill |
RedHill Biopharma Company Return On Equity Analysis
RedHill Biopharma's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current RedHill Biopharma Return On Equity | -246.27 |
Most of RedHill Biopharma's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RedHill Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, RedHill Biopharma has a Return On Equity of -246.27. This is much lower than that of the sector and significantly lower than that of the Return On Equity industry. The return on equity for all United States stocks is notably higher than that of the company.
RedHill Biopharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RedHill Biopharma's current stock value. Our valuation model uses many indicators to compare RedHill Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RedHill Biopharma competition to find correlations between indicators driving RedHill Biopharma's intrinsic value. More Info.RedHill Biopharma is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value RedHill Biopharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for RedHill Biopharma's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the RedHill Biopharma's earnings, one of the primary drivers of an investment's value.Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in RedHill Pink Sheet
If you are still planning to invest in RedHill Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RedHill Biopharma's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |